Terumo starts US-Japan stent trial
This article was originally published in Clinica
Executive Summary
Terumo Medical has initiated a trial of its Misago peripheral self-expanding stent for use in the superficial femoral artery (SFA). Called OSPREY, the study will simultaneously enrol patients in the US and Japan.
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.